📖 Overview
Marcia Angell is an American physician, author, and the first woman to serve as editor-in-chief of the New England Journal of Medicine (NEJM), holding that position from 1999 to 2000. Prior to becoming editor-in-chief, she spent nearly two decades as executive editor of the NEJM.
Throughout her career, Angell has been a prominent critic of the pharmaceutical industry and medical ethics, particularly through her influential book "The Truth About the Drug Companies: How They Deceive Us and What to Do About It" (2004). She has also written extensively about the commercialization of academic medical research and its impact on scientific integrity.
In her role as a senior lecturer at Harvard Medical School's Department of Global Health and Social Medicine, Angell has continued to address controversial issues in medicine and healthcare policy. Her writings frequently examine conflicts of interest in medical research and the relationship between physicians and pharmaceutical companies.
Angell's work has earned numerous honors, including election to the Association of American Physicians and the Institute of Medicine of the National Academy of Sciences. Her articles and books have significantly influenced discussions about healthcare reform and the role of commercial interests in medicine.
👀 Reviews
Readers praise Angell's clear explanations of complex medical and pharmaceutical industry issues. Many comments highlight her insider perspective from her time at the New England Journal of Medicine, lending credibility to her critiques.
What readers liked:
- Direct, evidence-based exposure of pharmaceutical industry practices
- Clear writing style accessible to non-medical readers
- Detailed documentation and research citations
- Solutions-focused approach to industry reform
What readers disliked:
- Some find her tone overly negative toward pharmaceutical companies
- Readers note certain sections become technical and dense
- Some argue her reform proposals are unrealistic
- Several mention the data feels dated in older works
Ratings across platforms:
- "The Truth About Drug Companies" (2004):
- Goodreads: 4.0/5 (2,100+ ratings)
- Amazon: 4.5/5 (300+ reviews)
- "Science on Trial" (1996):
- Goodreads: 3.8/5 (200+ ratings)
- Amazon: 4.2/5 (50+ reviews)
One reader noted: "Finally someone from inside medicine speaking truth about how pharma really operates."
📚 Books by Marcia Angell
Science on Trial: The Clash of Medical Evidence and the Law in the Breast Implant Case (1996)
Examines the scientific and legal issues surrounding silicon breast implant litigation and its impact on medical research and product development.
The Truth About the Drug Companies: How They Deceive Us and What to Do About It (2004) Details how pharmaceutical companies operate, their marketing practices, and their influence on medical research and drug pricing.
Patient Power: How to Protect Yourself from Medical Error (1997) Provides information about navigating the healthcare system and avoiding common medical mistakes.
Medicine on Trial (1988) Analyzes the relationship between medical practice and the legal system, focusing on medical malpractice cases and their consequences.
American Medicine: How the World's Best Medical Care is Failing Us (2007) Explores systemic problems in the U.S. healthcare system, including cost, access, and quality of care issues.
The Truth About the Drug Companies: How They Deceive Us and What to Do About It (2004) Details how pharmaceutical companies operate, their marketing practices, and their influence on medical research and drug pricing.
Patient Power: How to Protect Yourself from Medical Error (1997) Provides information about navigating the healthcare system and avoiding common medical mistakes.
Medicine on Trial (1988) Analyzes the relationship between medical practice and the legal system, focusing on medical malpractice cases and their consequences.
American Medicine: How the World's Best Medical Care is Failing Us (2007) Explores systemic problems in the U.S. healthcare system, including cost, access, and quality of care issues.
👥 Similar authors
Jerome Kassirer served as editor-in-chief of the New England Journal of Medicine and writes about conflicts of interest in medicine and healthcare policy. His work examines pharmaceutical industry influence on medical practice and research, similar to Angell's focus.
Ben Goldacre investigates pharmaceutical research practices and the misuse of science in medicine as a physician-researcher. He documents clinical trial transparency issues and evidence-based medicine challenges through systematic analysis.
Shannon Brownlee writes about overtreatment in medicine and systemic problems in healthcare delivery. Her research covers medical evidence quality and how financial incentives affect medical decision-making.
John Abramson examines how commercial influences shape medical research and clinical practice guidelines. His work analyzes pharmaceutical industry data and marketing practices that impact prescription drug use.
Carl Elliott investigates ethics in medicine and the pharmaceutical industry as a bioethicist and philosopher. His research focuses on human research subject exploitation and marketing's influence on medical practice.
Ben Goldacre investigates pharmaceutical research practices and the misuse of science in medicine as a physician-researcher. He documents clinical trial transparency issues and evidence-based medicine challenges through systematic analysis.
Shannon Brownlee writes about overtreatment in medicine and systemic problems in healthcare delivery. Her research covers medical evidence quality and how financial incentives affect medical decision-making.
John Abramson examines how commercial influences shape medical research and clinical practice guidelines. His work analyzes pharmaceutical industry data and marketing practices that impact prescription drug use.
Carl Elliott investigates ethics in medicine and the pharmaceutical industry as a bioethicist and philosopher. His research focuses on human research subject exploitation and marketing's influence on medical practice.